Online Quality by Design training offered at UK university
De Montfort University (DMU), Leicester, UK has launched a new training course for professionals working in the pharmaceutical and healthcare sectors.
The online Quality by Design (QbD) course is a work-based learning programme being taught by experts from leading pharmaceutical and healthcare companies including AstraZeneca, Pfizer, GlaxoSmithKline and Bristol-Myers Squibb, and supported by the Pharmaceutical Technologies Research Group at DMU.
The course will provide the tools and techniques to start using a ‘quality by design’ approach to developing pharmaceuticals.
A free industry event to launch the course is being held at DMU on 15 March from 4.30pm.
Keynote speeches will be delivered by Mike Hannay, medicines development vice-president at AstraZeneca; Martin Owen, API quality by design leader specialising in understanding uncertainty at GlaxoSmithKline; and Roger Weaver, research fellow, co-development right first time programme office at Pfizer.
Walkiria Schlindwein, QbD module leader at DMU, said: ‘This course is specifically designed to be flexible for businesses and can be studied in its entirety or as separate modules. Expert practitioners from 14 companies and consultancies are involved and all have hands-on ‘quality by design’ experience.’
GSK’s Owen added: ‘De Montfort University’s programme is a bold vision of collaborative creativity – bringing together a decentralised group of industrialists, consultants and academics to form a powerful crowd to drive a holistic understanding of ‘quality by design’.’